Hepatitis C Virus (HCV) is a significant global health concern, affecting millions of people worldwide. The virus is known for its ability to cause chronic liver diseases, including cirrhosis and hepatocellular carcinoma. Among the various proteins encoded by HCV, the non-structural protein 3 (NS3) plays a crucial role in the virus’s life cycle and pathogenesis.
The NS3 protein is a multifunctional enzyme with protease, helicase, and NTPase activities. It is essential for the processing of the HCV polyprotein and the replication of the viral RNA. The NS3 protease domain, located in the N-terminal region, cleaves the viral polyprotein at specific sites to generate mature viral proteins. The helicase domain, located in the C-terminal region, unwinds the viral RNA, facilitating its replication.
HCV is classified into several genotypes, with genotype 1 being the most prevalent and clinically significant. Genotype 1 is further divided into subtypes, including 1a, 1b, and 1c. Genotype-1c is less common but has been identified in various regions. The NS3 protein of genotype-1c shares similarities with other subtypes but also exhibits unique sequence variations that may influence its enzymatic activities and interactions with host factors.
The recombinant NS3 protein, encompassing amino acids 1192-1459, represents a specific region of the NS3 protein. This region includes the immunodominant epitopes, making it a valuable tool for diagnostic and research purposes. The recombinant protein is typically expressed in bacterial systems, such as E. coli, and purified using chromatographic techniques .
The recombinant NS3 protein is widely used in various applications: